Stanley Druckenmiller Invests $517 Million in Natera Inc.
- Druckenmiller’s Duquesne Family Office increased its stake in Natera by 4.19% in Q3.
- The firm now holds over 3.2 million shares worth $517.4 million.
- Natera represents 12.74% of the firm’s total $4.06 billion portfolio.
- The company reported a revenue growth of over 34% year-over-year in Q3.
Druckenmiller first invested in Natera when the stock was stagnant and has strategically increased his position during market fluctuations. Natera specializes in non-invasive DNA testing and has seen its stock price rise over 500% since October, with analysts predicting positive earnings by 2028.
This significant investment highlights Druckenmiller’s confidence in the future of healthcare technology as he positions his firm for potential long-term gains with Natera’s innovative offerings. (Source)
